Haw ParHAWPF 95 FCF Margin % is 27.75% as of Dec. 2025, which is 17% above its 10-year median of 23.79. GuruFocus rates HAWPF with a GF Score™ of 95/100 and a GF Value™ of $8.79. The stock has 3 warning signs investors should review. Among 958 Drug Manufacturers companies, Haw Par ranks better than 93.11% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Haw Par's Free Cash Flow for the
six
months ended in Dec. 2025 was $22.3 Mil. Haw Par's Revenue for the
six
months ended in Dec. 2025 was $80.3 Mil. Therefore, Haw Par's FCF Margin % for the quarter that ended in Dec. 2025 was 27.75%.
The historical rank and industry rank for Haw Par's FCF Margin % or its related term are showing as below:
HAWPF'
s FCF Margin % Range Over the Past 10 Years
Min: 10.24 Med: 23.79 Max: 44.01
Current: 23.91
During the past 13 years, the highest FCF Margin % of Haw Par was 44.01%. The lowest was 10.24%. And the median was 23.79%.
HAWPF's FCF Margin % is ranked better than 93.11% of 958
companies
in the Drug Manufacturers industry
Industry Median: 2.51
vs HAWPF: 23.91
Haw Par FCF Margin % Related Terms
Haw Par FCF Margin % Historical Data
* Premium members only.
The historical data trend for Haw Par's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Haw Par's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Haw Par FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Haw Par's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Haw Par's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Haw Par (HAWPF) has a FCF Margin % of 27.75% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Haw Par and its competitors. This is 17% above median its historical median of 23.79. Over the past decade, Haw Par's FCF Margin % has ranged from 10.24 to 44.01. According to the industry distribution chart, Haw Par ranks #66 out of 958 companies in the Drug Manufacturers industry, placing it in the top 6.9%.
Is Haw Par's FCF Margin % too high?
Haw Par's current FCF Margin % of 27.75% is 17% above median its 10-year median of 23.79. Over the past 10 years, this metric has ranged from a low of 10.24 to a high of 44.01. The Drug Manufacturers industry median FCF Margin % is 2.51. Haw Par's value of 27.75% is 1005.6% above this industry median. Based on the distribution chart, Haw Par ranks #66 out of 958 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Haw Par has a GF Score™ of 95/100, reflecting its overall financial health beyond just this single metric.
How does Haw Par's FCF Margin % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Haw Par ranks #66 out of 958 companies for FCF Margin %. This places Haw Par in the top 7% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 2.51. Haw Par's value of 27.75% is 1005.6% above this benchmark. Historically, Haw Par's own FCF Margin % has ranged from 10.24 to 44.01 over the past decade. While the company's 10-year median is 23.79 vs. the industry median of 2.51, Haw Par has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.51, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Haw Par's current FCF Margin % of 27.75% is 1005.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Haw Par and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Haw Par's current FCF Margin % is 27.75%, which is 17% above median its own 10-year median of 23.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haw Par stock overvalued right now?
Haw Par (HAWPF) has a current FCF Margin % of 27.75%. The stock's GF Value™ is $8.79, compared to a current price of $12.00 — trading 36.5% above its estimated fair value. The current FCF Margin % is 27.75%, which is 17% above median its 10-year median of 23.79 and 1005.6% above the Drug Manufacturers industry median of 2.51. Haw Par's overall GF Score™ is 95/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Haw Par (HAWPF), the current FCF Margin % is 27.75% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Haw Par (HAWPF) Overvalued in 2026?
Based on GuruFocus' analysis, Haw Par stock appears to be overvalued.
The current stock price of $12.00 is trading 36.5% above its estimated GF Value™ of $8.79.
Key valuation signals for HAWPF:
FCF Margin %: 27.75% (17% above median its 10-year median of 23.79)
GF Value™: $8.79 vs. price of $12.00 (36.5% above fair value)
Industry Position: 1005.6% above the Drug Manufacturers median (#66 of 958)
No single metric tells the full story. See the HAWPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Haw Par Corp Ltd is a drug manufacturing company that operates multiple brands. The company is to expand its core businesses through product brand extension, strategic alliances, and exploring potential acquisitions. Its operating segments include the Healthcare segment, Investments segment, Property segment, and Leisure segment. The company generates the majority of its revenue from the Healthcare segment. Its Healthcare segment manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands. Geographically, it generates key revenue from the other ASEAN and other Asian countries.
95GF Score
Get the complete analysis for HAWPF
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAWPF has been successfully added to your 
